PRI/Reddy Cheminor alliance is new model, providing cost-effective bulk chemicals security of supply -- PRI.
PRI/REDDY CHEMINOR ALLIANCE OFFERS COST-EFFECTIVE BULK DRUG SUPPLY SECURITY through less expensive overseas finished formulation and cheaper transfer pricing of bulk pharmaceutical chemicals, Pharmaceutical Resources, Inc. CEO Kenneth Sawyer said at the Dillon Read generic drugs/delivery systems investor conference May 7. Sawyer called the 1996 product alliance with India's Reddy Cheminor a model for the future of the generic drug industry.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth